NOS3 and rheumatoid arthritis: Additionally, PIK3CA, AKT1, MAPK9, PRKCD, BRAF, IGF1R, and NOS3 were among the common target genes that were involved in reducing the severity of RA when different phytocannabinoids were used as treatment.